Small Starting Margins in Mohs Surgery for Early Melanoma Do Not Raise Death Risk, Study Finds

When a surgeon removes an early-stage melanoma, one of the most consequential decisions happens before the first incision: how wide should the initial margin of skin around the visible tumor be? For decades, surgical guidelines have prescribed generous excision margins for melanoma, on the assumption that cutting well beyond the visible edge of the tumor reduces the chance that malignant cells are left behind to seed a recurrence. But a new study from researchers at Mayo Clinic suggests that, at least for the earliest and thinnest melanomas treated with Mohs micrographic surgery, the size of that initial margin may matter far less than surgeons have long assumed. In a review of 326 patients with thin melanomas treated over a decade, only two deaths were attributable to melanoma, and the initial margin sizes chosen by surgeons showed no statistically significant relationship with disease-specific mortality.

The study, published as a short report in the Archives of Dermatological Research, examined patients with stage T1a and T1b melanomas—lesions that are, by definition, thin and caught early—who were treated with Mohs micrographic surgery between 2008 and 2018 at a single tertiary care academic institution. The researchers combed patient charts to record three key variables for each case: the initial margin used when Mohs surgery began, whether the melanoma recurred, and whether the patient ultimately died of melanoma. Statistical analysis then tested whether the width of the starting margin influenced the risk of dying from the disease. The answer, according to the data, was no.

Only two of the 326 patients died from melanoma during the follow-up period, and both of those patients had received relatively generous initial margins of 8 millimeters and 10 millimeters respectively. That detail is striking because it runs counter to the intuitive logic that wider margins should offer greater protection. With such a small number of events, the study cannot definitively prove that margin size is irrelevant to survival, but the near-total absence of melanoma deaths across a decade of patients—regardless of whether surgeons started with margins smaller or larger than one centimeter—adds to a growing body of evidence that the initial margin in Mohs surgery is not a critical determinant of survival outcomes.

To understand why this finding is significant, it helps to consider what makes Mohs micrographic surgery fundamentally different from a conventional wide local excision. In a standard excision, the surgeon removes the tumor along with a predetermined cuff of healthy-appearing skin, and the specimen is sent to a pathology laboratory where tissue is sampled at intervals—often through vertical sectioning that examines only a small fraction of the true margin. If malignant cells remain at the surgical edge, they may escape detection. Mohs surgery, by contrast, is built around complete margin control. The surgeon removes the visible tumor with a thin initial layer, then processes that tissue so that 100 percent of the peripheral and deep margins can be examined under the microscope while the patient waits. If cancer cells are identified anywhere along the margin, the surgeon maps their location and removes another thin layer precisely where the disease persists, repeating the process until the margins are entirely clear.

It is this exhaustive margin evaluation, the study’s authors argue, that likely explains why the initial margin width does not influence melanoma-specific mortality. When the first excision is narrow and tumor extends beyond it, the Mohs technique detects and removes those residual cells in subsequent stages. When the first excision is wide, fewer stages may be needed, but the final result—histologically clear margins—is the same. In other words, the initial margin functions less as a therapeutic boundary and more as a starting point for an iterative process whose endpoint is defined by microscopic confirmation rather than by a measurement taken before the first cut. The safety net of complete margin evaluation means that a conservative starting margin does not translate into a higher risk of leaving disease behind.

The choice of initial margins in Mohs surgery for melanoma has long been both variable and controversial. Many surgeons opt for starting margins of less than one centimeter, reasoning that the technique’s complete margin assessment makes large initial cuffs unnecessary and that smaller initial excisions spare more healthy tissue—a consideration of particular importance on the face, ears, and other cosmetically and functionally sensitive sites where melanomas are common. Others have argued for wider initial margins, extrapolating from guidelines developed for wide local excision, where the margin itself is the primary safeguard against residual disease. The new findings lend support to the former camp, suggesting that conservative starting margins in Mohs surgery do not compromise survival.

The results also align with a broader shift in the evidence base surrounding Mohs surgery for melanoma. A 2022 systematic review and meta-analysis found that local recurrence of melanoma is higher after wide local excision than after Mohs micrographic surgery or staged excision, challenging the assumption that the traditional approach offers superior local control. A 2023 systematic review and meta-analysis focused specifically on margins concluded that disease-specific survival after Mohs surgery is not impacted by initial margin selection, and a separate National Cancer Database analysis published the same year found no survival benefit associated with wide-margin Mohs surgery for melanoma. Studies comparing the two techniques directly have reported that Mohs surgery is associated with excellent efficacy and low recurrence rates, and some database analyses have even suggested improved overall survival for melanomas of the head, neck, trunk, and extremities treated with the Mohs approach compared with wide local excision.

Historically, the use of Mohs micrographic surgery for melanoma was itself contentious, with early guidelines favoring wide local excision as the standard of care for all invasive melanomas. Concerns centered on whether the technical demands of processing melanoma tissue—interpreting atypical melanocytes at margins is more subtle than assessing epithelial cancers such as basal cell or squamous cell carcinoma—could be met reliably. Over time, refinements in technique, including the use of immunohistochemical stains that highlight melanocytes, and accumulating outcome data have eroded that skepticism. A 2021 systematic review catalogued the many technical variations now in use for Mohs surgery for melanoma, and current practice guidelines have evolved to acknowledge the technique’s role, particularly for melanomas arising in anatomically constrained locations where wide excision would cause significant morbidity.

The authors of the new report are careful to note the limitations of their work. The study was retrospective, relying on chart review rather than prospective randomization, which introduces the possibility of unmeasured confounding. The cohort, while sizable for a single institution, was limited in number, and the range of initial margin sizes actually used by surgeons constrained the statistical power to detect small effects. Most importantly, only two melanoma deaths occurred in the entire cohort, which means the analysis rests on an extremely small number of events. A truly definitive answer to the margin question would require a much larger, ideally multi-center or randomized comparison. Nevertheless, the consistency of the finding with prior meta-analytic evidence strengthens the case that initial margin selection is not a survival-critical variable in this setting.

For patients with thin melanomas, the practical implications are encouraging. The study suggests that surgeons using Mohs micrographic surgery can select conservative initial margins without fear of compromising survival, provided the technique’s complete margin evaluation is performed rigorously. Smaller initial excisions mean less tissue removed, smaller defects to reconstruct, and potentially better cosmetic and functional outcomes—benefits that are especially meaningful when melanomas arise on the face and other visible or functionally critical sites. As evidence accumulates that margin selection in Mohs surgery for early melanoma does not affect disease-specific mortality, the conversation among surgeons may shift from how wide to start toward how to optimize the iterative margin-mapping process itself, ensuring that the microscopic certainty that defines the technique remains its true protective power.

Subject of Research: The effect of initial Mohs micrographic surgery margin size on disease-specific mortality in patients with early-stage melanoma.

Article Title: Impact of initial Mohs micrographic surgery margins for melanoma on disease specific mortality

Article References: Cull, D., Campbell, E., Bangalore-Kumar, A., Trischman, T., Asamoah, E., Vidal, N. Y., & Demer, A. (2026). Impact of initial Mohs micrographic surgery margins for melanoma on disease specific mortality. Archives of Dermatological Research, 318(1), Article 453. https://doi.org/10.1007/s00403-026-04904-0

Image Credits: AI Generated

DOI: 10.1007/s00403-026-04904-0

Keywords: Mohs micrographic surgery, melanoma, surgical margins, disease-specific mortality, skin cancer, wide local excision, T1 melanoma, margin control, dermatologic surgery, melanoma survival, recurrence, surgical oncology